19
Growth Score
pts
Heat Score
2 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
Ethicann Pharmaceuticals uses pharmaceutical-grade botanically sourced cannabinoid oils to formulate ethical drugs.
- Bruce Mackler: EVP of Regulatory & Clinical Affairs; Board Director; Co-Founder
- Brandon Price: Co-Founder and Board MemberPast Role: Cognate BioServices, Chief Executive Officer
About the Company
Ethicann Pharmaceuticals uses pharmaceutical-grade botanically sourced cannabinoid oils to formulate ethical drugs. It targets several different large-market diseases for its THC+CBD ethical pharmaceutical drugs; namely and in order of launch, spasticity from multiple sclerosis, adult focal epilepsy, chemotherapy-induced nausea and vomiting (CINV),
and chronic pain from cancer.
